Prurigo Nodularis: Recognizing, Diagnosing and Treating a Rare but Debilitating Disease

To participate in this activity, please:

Log in Sign Up

Prurigo Nodularis is a rare, chronic skin disorder that causes substantial patient burden, but is often overlooked or misdiagnosed and, until recently, had no medications approved by the US Food and Drug Administration. The interprofessional faculty share their real-world perspectives on the diagnosis and treatment of patients with prurigo nodularis to reduce patient burden of disease and improve health outcomes. Highlighting pathophysiologic mechanisms, the faculty discuss the evolving pharmacologic treatment of patients with prurigo nodularis that now includes dupilumab; they also review safety and efficacy data for medications in late-phase clinical investigation. Case studies are discussed to facilitate integration of key concepts into clinical practice.

Course Credit:

1.50 AAPA Category I CME Credits
1.50 ACPE Contact Hours
1.50 AMA PRA Category 1 CreditsTM
1.50 ANCC Contact Hours
1.50 CA-BRN Contact Hours
1.00 Pharmacology Hour

Dates:

Opens: 2023-08-31
Closes: 2024-08-31

Target Audience:

Dermatologists, dermatology nurse practitioners and physician associates/assistants, nurses, pharmacists, and other clinicians who may be involved in the management of patients diagnosed with prurigo nodularis, including those in primary care, allergy, immunology, and psychiatry.

This activity is supported by educational grants from Galderma, and Sanofi and Regeneron Pharmaceuticals.

Accreditation Information

    Presenting Faculty

  • Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES

    Associate Professor of Pharmacy Practice
    Duquesne University
    Pittsburgh, Pennsylvania

  • Leigh Ann Pansch, MSN, FNP-BC, DCNP

    Dermatologists of Central States
    Cincinnati, Ohio 

  • Jonathan I. Silverberg, MD, PhD, MPH

    Professor
    Director of Clinical Research
    Director of Patch Testing
    George Washington University School of Medicine and Health Sciences
    Washington, DC

  • Lindsay C. Strowd, MD

    Associate Professor and Interim Chair
    Director of Inpatient Consultative Dermatology
    Director of Clinical Studies Unit
    Department of Dermatology
    Director of Developing Initiatives
    Office of Academic Affairs
    Wake Forest School of Medicine
    Winston-Salem, North Carolina

  • Najat M. Watch, PA-C

    Department of Dermatology
    Henry Ford Health System
    Dearborn, Michigan